SXTC.US China SXT Pharmaceuticals Inc

Healthcare Personal Care Products USA Stocks
2.86 USD
Close of Nov 18, 2026
2.71 1,000,000
Market cap
USD 296K
P/E
-
P/B
0.01x
ROE
2.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is SXTC.US undervalued?

Graham number

The Graham number of China SXT Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

China SXT Pharmaceuticals Inc fundamental analysis

No fundamental analysis for China SXT Pharmaceuticals Inc yet.

China SXT Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About China SXT Pharmaceuticals Inc

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKui…

Full company profile